1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 3: 
Comparison of main baseline characteristics in patients with and without ischemic events after carotid occlusion (n = 56)
CharacteristicsIschemic Events (n = 18)No Ischemic Events (n = 38)P Value
Age (yr) median (Q1–Q3)55 (50–64)52 (43–67).477
Female (No.) (%)18 (100)33 (86).131
Vascular risk factor (No.) (%)14 (78)17 (44).032
Antiplatelet therapy (No.) (%)5 (28)10 (36).856
Giant aneurysms (≥25 mm) (No.) (%)7 (39)20 (53).336
Fusiform aneurysms (No.) (%)1 (6)4 (10).479
Infraclinoid aneurysms (No.) (%)11 (61)31 (82).099
Mural thrombus (No.) (%)1 (6)14 (37).011
Delay of phlebogram ≥2 sec (No.) (%)4 (22)3 (8).140